Drug intelligence / Profile preview

SFT 4002

Development stage
Unknown
Lead developer
invoX Pharma
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Inhalation
01

Overview

**SFT 4002** is an investigational inhaled respiratory drug-device combination program developed by invoX Pharma for **asthma** and **chronic obstructive pulmonary disease**. invoX lists the candidate in its Softhaler® respiratory pipeline at Phase 2. The active pharmaceutical ingredient, molecular modality, pharmacologic target, and mechanism of action have not been publicly disclosed. Softhaler® is a propellant-free soft-mist inhalation platform that mechanically converts a liquid formulation into an ultra-fine aerosol for pulmonary delivery; it is not a dry-powder inhaler.

Other names
SFT-4002SFT4002SFT 4002
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on SFT 4002.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SFT 4002.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call